Evidence map›Paper›PMID 28770317›Full record

ArticleDiabetologia2017

Mitochondrial H

Laura Formentini, Alexander J Ryan, Manuel Gálvez-Santisteban, Leslie Carter, Pam Taub, John D Lapek, David J Gonzalez, Francisco Villarreal, Theodore P Ciaraldi, José M Cuezva and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Laura FormentiniVA San Diego Healthcare System, San Diego, CA, USA. lformentini@cbm.csic.es.ORCID http://orcid.org/0000-0001-5641-821X
Alexander J RyanVA San Diego Healthcare System, San Diego, CA, USA.
Manuel Gálvez-SantistebanDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Leslie CarterVA San Diego Healthcare System, San Diego, CA, USA.
Pam TaubVA San Diego Healthcare System, San Diego, CA, USA.
John D LapekDepartment of Pharmacology and Pharmacy, University of California, San Diego, La Jolla, CA, USA.
David J GonzalezDepartment of Pharmacology and Pharmacy, University of California, San Diego, La Jolla, CA, USA.
Francisco VillarrealDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Theodore P CiaraldiVA San Diego Healthcare System, San Diego, CA, USA.
José M CuezvaDepartamento de Biología Molecular, CIBER Enfermedades Raras, Centro de Biología Molecular 'Severo Ochoa' (CBMSO), c/ Nicolás Cabrera 1, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
Robert R HenryVA San Diego Healthcare System, San Diego, CA, USA.
University of California San Diego · USCentro de Investigación Biomédica en Red · ESUniversity of Manchester · GBVA San Diego Healthcare System · US

Funding

Epicatechin and derivatives to preserve muscle structure function in diabetesR01DK098717 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HENRY, ROBERT ROY, VILLARREAL, FRANCISCO J · 2014 to 2017
$1.4M
Function of the Myo-adipo Axis in Human Obesity and Type 2 DiabetesI01CX000635 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HENRY, ROBERT ROY · 2012 to 2015
–
CSRD VA I01 CX000635NIDDK NIH HHS R01 DK098717
6 · The paper itself

Abstract

aims/hypothesisMitochondria are important regulators of the metabolic phenotype in type 2 diabetes. A key factor in mitochondrial physiology is the H

methodsWe examined the 'mitochondrial signature' of obesity and type 2 diabetes in a cohort of 100 metabolically characterised human skeletal muscle biopsy samples. The expression and activity of H

resultsThe results indicate that type 2 diabetes and obesity act via different mechanisms to impair H CONCLUSIONS/

interpretationOverall, our data highlight IF1 as a novel regulator of lipid metabolism and metabolic disorders, and a possible target for therapeutic intervention.

Indexed as

Diabetes Mellitus, Type 2DyslipidemiasFemaleHumansInsulin ResistanceMaleMitochondrial Proton-Translocating ATPasesMitochondria, MuscleMuscle, SkeletalObesityProteomicsMitochondrial Proton-Translocating ATPasesEnergy metabolismH+-ATP synthaseInhibitory factor 1 (IF1)MitochondriaObesitySkeletal muscleType 2 diabetes

Identifiers

PMID28770317
PMCPMC6572787
OpenAlexW2739682907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.